OncoSec Medical Incorporated (ONCS) Stock Price & Overview
NASDAQ:ONCS • US68234L4059
Current stock price
The current stock price of ONCS is 0.2772 USD. Today ONCS is up by 31.87%. In the past month the price decreased by -44.42%. In the past year, price decreased by -98.4%.
ONCS Key Statistics
- Market Cap
- 1.653M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -19.14
- Dividend Yield
- N/A
ONCS Stock Performance
ONCS Stock Chart
ONCS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to ONCS. When comparing the yearly performance of all stocks, ONCS is a bad performer in the overall market: 99.9% of all stocks are doing better.
ONCS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ONCS. ONCS may be in some trouble as it scores bad on both profitability and health.
ONCS Earnings
ONCS Forecast & Estimates
6 analysts have analysed ONCS and the average price target is 5.1 USD. This implies a price increase of 1739.83% is expected in the next year compared to the current price of 0.2772.
ONCS Groups
Sector & Classification
ONCS Financial Highlights
Over the last trailing twelve months ONCS reported a non-GAAP Earnings per Share(EPS) of -19.14. The EPS increased by 39.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ONCS Ownership
ONCS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ONCS
Company Profile
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. The company is headquartered in Ewing, New Jersey and currently employs 40 full-time employees. The company went IPO on 2015-05-29. The firm is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its technology platform, ImmunoPulse, is a drug-device therapeutic modality comprised of intertumoral EP delivery devices, such as the OncoSec Medical System (OMS) EP device. The OMS EP device is designed to deliver plasmid DNA-encoded drugs directly into a solid tumor and promote an immunological response against cancer. The OMS EP device adapts to treat different tumor types and consists of an electrical pulse generator, a reusable handle and disposable applicators. Its product candidate, TAVO is a drug-device combination. The drug consists of a plasmid construct called tavokinogene telseplasmid (TAVO) with plasmid DNA-encoded, IL-12, and is delivered into a tumor using its electroporation device.
Company Info
IPO: 2015-05-29
OncoSec Medical Incorporated
820 Bear Tavern Road
Ewing NEW JERSEY 08534 US
CEO: Margaret Dalesandro
Employees: 40
Phone: 18582107333.0
OncoSec Medical Incorporated / ONCS FAQ
What does OncoSec Medical Incorporated do?
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. The company is headquartered in Ewing, New Jersey and currently employs 40 full-time employees. The company went IPO on 2015-05-29. The firm is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its technology platform, ImmunoPulse, is a drug-device therapeutic modality comprised of intertumoral EP delivery devices, such as the OncoSec Medical System (OMS) EP device. The OMS EP device is designed to deliver plasmid DNA-encoded drugs directly into a solid tumor and promote an immunological response against cancer. The OMS EP device adapts to treat different tumor types and consists of an electrical pulse generator, a reusable handle and disposable applicators. Its product candidate, TAVO is a drug-device combination. The drug consists of a plasmid construct called tavokinogene telseplasmid (TAVO) with plasmid DNA-encoded, IL-12, and is delivered into a tumor using its electroporation device.
What is the current price of ONCS stock?
The current stock price of ONCS is 0.2772 USD. The price increased by 31.87% in the last trading session.
Does OncoSec Medical Incorporated pay dividends?
ONCS does not pay a dividend.
What is the ChartMill rating of OncoSec Medical Incorporated stock?
ONCS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does OncoSec Medical Incorporated belong to?
OncoSec Medical Incorporated (ONCS) operates in the Health Care sector and the Biotechnology industry.
What is the market capitalization of ONCS stock?
OncoSec Medical Incorporated (ONCS) has a market capitalization of 1.65M USD. This makes ONCS a Nano Cap stock.